Neuroscience
From The New York Times:
-
Anthony H. Risser | neuroscience | neuropsychology | brain | neurology
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Missing Meningitis In A Flaky/dodgy Swine Flu System: Another Case
Yet another case from the UK: Woman dies of meningitis after swine flu diagnosis • Woman prescribed Tamiflu and paracetamol dies in hospital • Son urges doctors to heed symptoms of other illnesses Karen McVeigh guardian.co.uk Wednesday 12 August 2009...
- H1n1 (swine Flu) Vaccine Product: Alphavax And Gsk
Alphavax, of Research Triangle Park, reported completing preclinical work and is developing product for clinical trials of its H1N1 (Swine Flu) vaccine, per company press release (click here). GlaxoSmithKline (GSK) tasks order for 195 million doses of...
- Meningitis
From The New York Times:City Tackles Meningitis in Brooklyn By RICHARD PÉREZ-PEÑA The New York Times 29 June 2006 City health officials yesterday announced a novel assault on a large meningitis outbreak in Brooklyn, seeking to vaccinate thousands of...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...
Neuroscience
Meningococcal Disease and Menactra Vaccine
From The New York Times:
Wider Student Use Is Urged for New Meningitis Vaccine[ ... Read the full article ... ]
By LAWRENCE K. ALTMAN
The New York Times
Published: May 27, 2005
The Centers for Disease Control and Prevention recommended yesterday wider use of a new meningitis vaccine for adolescents and college freshmen.
The vaccine, sold as Menactra by Sanofi Pasteur, protects against infections caused by meningococcal bacteria. Such infections include a form of meningitis that can be rapidly fatal.
For the first time, the diseases center, a federal agency in Atlanta, recommended that all 11- and 12-year-olds be routinely immunized against meningococcal disease.
The agency also recommended using Menactra to protect high school freshmen or children younger than 15, whichever comes earlier.
In a third recommendation, the agency recommended that all college freshmen living in dormitories be immunized against meningococcal disease. The new recommendation strengthened an earlier one that said freshmen should consider such protection.
-
Anthony H. Risser | neuroscience | neuropsychology | brain | neurology
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Missing Meningitis In A Flaky/dodgy Swine Flu System: Another Case
Yet another case from the UK: Woman dies of meningitis after swine flu diagnosis • Woman prescribed Tamiflu and paracetamol dies in hospital • Son urges doctors to heed symptoms of other illnesses Karen McVeigh guardian.co.uk Wednesday 12 August 2009...
- H1n1 (swine Flu) Vaccine Product: Alphavax And Gsk
Alphavax, of Research Triangle Park, reported completing preclinical work and is developing product for clinical trials of its H1N1 (Swine Flu) vaccine, per company press release (click here). GlaxoSmithKline (GSK) tasks order for 195 million doses of...
- Meningitis
From The New York Times:City Tackles Meningitis in Brooklyn By RICHARD PÉREZ-PEÑA The New York Times 29 June 2006 City health officials yesterday announced a novel assault on a large meningitis outbreak in Brooklyn, seeking to vaccinate thousands of...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...